Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • Gastroenterology
  • Gastroenterology News
  • Ulinastatin and...

Ulinastatin and somatostatin combo lowers risk of complications in acute pancreatitis

Written By : Dr. Kamal Kant Kohli Published On 1 Nov 2022 2:00 PM  |  Updated On 1 Nov 2022 3:43 PM
Ulinastatin and somatostatin combo lowers risk of complications in acute pancreatitis
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

HUNGARY: According to a research study published in the journal Scientific Reports, ulinastatin in combination with a somatostatin analogue substantially reduced the rate of complications in acute pancreatitis when compared to somatostatin analogue monotherapy.

The abrupt inflammation of the pancreas is known as acute pancreatitis (AP). Better patient outcomes require the early detection and management of AP. There isn't a single pharmaceutical agent available currently to treat acute pancreatitis (AP). The efficacy of somatostatin and its equivalents in preventing the autolysis of the pancreas in AP has not been established. Several clinical trials involving the combination of ulinastatin and somatostatin or its counterpart octreotide produced encouraging findings, but the strength of the evidence is still weak.

This study compared the effectiveness and safety of somatostatin derivatives alone to ulinastatin combined with somatostatin or octreotide in the treatment of acute pancreatitis.

In order to find randomized controlled trials where the effectiveness of ulinastatin combined with somatostatin analogue was compared to somatostatin analogue alone in patients with AP, the authors did a systematic database search in 4 databases. Because the patient populations of the examined studies' patient populations varied slightly, they employed random effect models to calculate odds ratios (OR), mean differences (MD), and the accompanying 95% confidence intervals (CI). The meta-analysis included a total of 9 studies with a combined 1037 patients. The main outcomes were mortality, complications, including Acute Respiratory Distress Syndrome (ARDS), shock, Acute Kidney Injury (AKI), Multiple Organ Dysfunction Syndrome (MODS), and hospital stay duration.They assessed adverse events, changes in laboratory markers, and the rate of symptom reduction as secondary outcomes.

Key highlights of the study:

  • The incidences of ARDS and AKI were reduced by around 70% with the combination therapy [OR 0.27; 95% CI 0.13-0.60; I2 = 28%] and [OR 0.29; 95% CI 0.09.-0.97; I2 = 49%], respectively, whereas MODS could be avoided in about 60% of cases [OR 0.39; 95% CI 0.20-0.75; I2 = 0%].
  • The reduction in shock incidence [OR 0.46; 95% CI 0.20-1.07; I2 = 39%] was not statistically significant.
  • reduced death rate was shown with the combined therapy [OR 0.55; 95% CI 0.29-1.07; I2 = 0%]; nevertheless, the outcome was not statistically significant.
  • In comparison to the control group, the intervention group's admission time was cut by 9.43 days (95% CI (-12.55)-(-6.31); I2 = 97%).
  • When compared to somatostatin alone, combined therapy dramatically provided a threefold reduction in symptom relief.

"It is a clinically beneficial therapy with fewer days spent in the hospital and lower complication rates. Both short-term and long-term savings could be made on additional health care costs "the researchers wrote.

In the treatment of AP, somatostatin analogue monotherapy is insufficiently successful. It should be further researched, they added, even though the results provided here indicate an improvement in efficacy when paired with ulinastatin.

The authors came to the conclusion that this meta-analysis offers fresh information regarding a potential pharmacological therapy treatment for acute pancreatitis. Given the limited number of available treatments and the high death rate, this is particularly crucial in severe situations.

REFERENCE

Horváth, I.L., Bunduc, S., Fehérvári, P. et al. The combination of ulinastatin and somatostatin reduces complication rates in acute pancreatitis: a systematic review and meta-analysis of randomized controlled trials. Sci Rep 12, 17979 (2022). https://doi.org/10.1038/s41598-022-22341-7

Scientific Reportsulinastatinsomatostatinacute pancreatitisoctreotideAcute Respiratory Distress Syndrome (ARDS)shockAcute Kidney Injury (AKI)Multiple Organ Dysfunction Syndrome (MODS)
Source : Scientific Reports
Dr. Kamal Kant Kohli
Dr. Kamal Kant Kohli

Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

Show Full Article
Next Story

Editorial

Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases

Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases

Prediabetes and the Mind: Unraveling Cognitive and Mental Health Risks

Prediabetes and the Mind: Unraveling Cognitive and Mental Health Risks

Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Aditya Murali

Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer...

View All

Journal Club Today

Ajanta Pharma Launches Met-XL D to Improve Outcomes for Heart Failure and Post-Myocardial Infarction Patients

Ajanta Pharma Launches Met-XL D to Improve Outcomes for Heart Failure and Post-Myocardial Infarction...

View All

Health News Today

Health Bulletin 22/ May/ 2025

Health Bulletin 22/ May/ 2025

View All
© 2022 All Rights Reserved.
Powered By: Hocalwire
X
We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok